Literature DB >> 29948179

Quantification of radiation retinopathy after beam proton irradiation in centrally located choroidal melanoma.

Catharina Busch1,2, Julia Löwen1, Daniel Pilger1, Ira Seibel1, Jens Heufelder3, Antonia M Joussen4.   

Abstract

PURPOSE: To localize and quantify ischemic changes induced by proton beam irradiation of central choroidal melanoma and to identify baseline predictors correlated with the extent of ischemic changes.
METHODS: Retrospective chart review of patients with central choroidal melanoma treated by proton beam irradiation and conducted widefield fluorescein angiography (≥ 20 months after radiation therapy). Quantification and location of ischemic areas and correlation to baseline predictors. Multiple linear regression model was performed for analyses.
RESULTS: Twenty-five eyes from 25 patients were included in final analysis. Mean largest basal tumor area was 56.6 ± 40.0 mm2 and mean maximal tumor prominence 2.5 ± 1.4 mm. Mean total radiated area was 339.1 ± 68.3 mm2. All patients showed ischemic changes. Mean ischemic area was 387.6 ± 123.3 mm2 and mean ischemic index (ischemic area/total visible area) was 0.53 ± 0.23. Twenty-two patients (88%) presented ischemic changes outside of the irradiation field, which comprised of 23% of total ischemic area. Mean angular distance between lateral border of irradiation field and ischemic area outside of the radiated area was 44.8 ± 36.5°. Multivariable analysis revealed a positive correlation of total ischemic area with total radiated area (p = 0.02) and initial sonographic tumor prominence (p = 0.02).
CONCLUSIONS: Ischemic changes induced by proton beam irradiation of central choroidal melanoma were localized and quantified. Ischemic changes exceed the tumor area distinctly and are found also outside of the irradiation field in the majority of patients. Size of irradiation area and tumor prominence are positively correlated with extent of ischemic area.

Entities:  

Keywords:  Choroidal melanoma; Proton beam therapy; Radiation retinopathy; Retinal ischemia

Mesh:

Year:  2018        PMID: 29948179     DOI: 10.1007/s00417-018-4036-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  11 in total

1.  Real-time dose calculation and visualization for the proton therapy of ocular tumours.

Authors:  K Pfeiffer; R Bendl
Journal:  Phys Med Biol       Date:  2001-03       Impact factor: 3.609

2.  Precise modelling of the eye for proton therapy of intra-ocular tumours.

Authors:  Barbara Dobler; Rolf Bendl
Journal:  Phys Med Biol       Date:  2002-02-21       Impact factor: 3.609

3.  Characterization of ischemic index using ultra-widefield fluorescein angiography in patients with focal and diffuse recalcitrant diabetic macular edema.

Authors:  Ravi D Patel; Leonard V Messner; Bruce Teitelbaum; Kimberly A Michel; Seenu M Hariprasad
Journal:  Am J Ophthalmol       Date:  2013-02-27       Impact factor: 5.258

4.  Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.

Authors:  Ira Seibel; Aline I Riechardt; Jens Heufelder; Dino Cordini; Antonia M Joussen
Journal:  Am J Ophthalmol       Date:  2017-03-30       Impact factor: 5.258

5.  Ultra-widefield Imaging of the Peripheral Retinal Vasculature in Normal Subjects.

Authors:  Michael Singer; Min Sagong; Jano van Hemert; Laura Kuehlewein; Darren Bell; SriniVas R Sadda
Journal:  Ophthalmology       Date:  2016-02-17       Impact factor: 12.079

6.  Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency.

Authors:  L A Peña; Z Fuks; R N Kolesnick
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

7.  Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma.

Authors:  K Gündüz; C L Shields; J A Shields; J Cater; J E Freire; L W Brady
Journal:  Arch Ophthalmol       Date:  1999-05

8.  Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases.

Authors:  Mandeep S Sagoo; Carol L Shields; Jacqueline Emrich; Arman Mashayekhi; Lydia Komarnicky; Jerry A Shields
Journal:  JAMA Ophthalmol       Date:  2014-06       Impact factor: 7.389

9.  [Five years of proton therapy of eye neoplasms at the Hahn-Meitner Institute, Berlin].

Authors:  Jens Heufelder; Dino Cordini; Hermann Fuchs; Jürgen Heese; Heinrich Homeyer; Heinz Kluge; Hans Morgenstern; Stefan Höcht; Martin Nausner; Nikolaos E Bechrakis; Wolfgang Hinkelbein; Michael H Foerster
Journal:  Z Med Phys       Date:  2004       Impact factor: 4.820

10.  WIDEFIELD FLUORESCEIN ANGIOGRAPHY IN PATIENTS WITHOUT PERIPHERAL DISEASE: A Study of Normal Peripheral Findings.

Authors:  Ankoor R Shah; Ashkan M Abbey; Yoshihiro Yonekawa; Sara Khandan; Jeremy D Wolfe; Michael T Trese; George A Williams; Antonio Capone
Journal:  Retina       Date:  2016-06       Impact factor: 4.256

View more
  1 in total

1.  Prospective Assessment of Early Proton Therapy-Induced Optic Neuropathy in Patients With Intracranial, Orbital or Sinonasal Tumors: Impact of A Standardized Ophthalmological Follow Up.

Authors:  Marie Lecornu; Paul Lesueur; Julia Salleron; Jacques Balosso; Dinu Stefan; William Kao; Tiphaine Plouhinec; Anthony Vela; Pauline Dutheil; Jordan Bouter; Pierre-Alban Marty; Juliette Thariat; Jean-Claude Quintyn
Journal:  Front Oncol       Date:  2021-06-15       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.